Acinic Cell Carcinoma - 45 Studies Found
| Active, not recruiting |
: Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer :
|
| Recruiting |
: High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery :
: |
| Recruiting |
: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery :
|
| Recruiting |
: ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery :
|
| Withdrawn |
: Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung :
|
| Completed |
: Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies :
|
| Active, not recruiting |
: Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery :
|
| Terminated |
: Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer :
: |
| Active, not recruiting |
: Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors :
|
| Completed |
: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers :
: 2004-11-05 : |